More on RXST

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-24.1% Growth)
- Ratings (0.8 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

RxSight (NQ:RXST)
Delayed: 5.51 +0.32 (6.17%)
Prev. Close $5.19  
Open$5.25 
52 Wk High$ 
52 Wk Low$ 
Day High$5.59 
Day Low$5.25 
P/E N/A  
EPS$ 
Volume417,178 

Friends, Peers and Foes (?): KMTS, NSPR, AXNX, ANRO, LAZR (more...)

Jul 26, 2026 04:00 PM RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
Jul 24, 2026 08:08 PM Form 4 RxSight, Inc. For: Jul 24 Filed by: Mottiwala Aziz
Jul 24, 2026 08:06 PM Form 3 RxSight, Inc. For: Jul 20 Filed by: Mottiwala Aziz
Jul 23, 2026 04:53 PM Form S-8 RxSight, Inc.
Jul 17, 2026 11:34 AM Form SCHEDULE 13G RxSight, Inc. Filed by: BlackRock Portfolio Management LLC
Jul 15, 2026 04:24 PM Form 8-K RxSight, Inc. For: Jul 13
Jul 15, 2026 04:15 PM RxSight names Mottiwala as CEO, Kurtz shifts to chief medical officer
Jul 15, 2026 04:15 PM RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
Jul 7, 2026 12:24 PM RxSight Inc. (RXST) PT Lowered to $6.50 at BofA Securities
Jul 7, 2026 06:56 AM RxSight (RXST) Reiterated at Hold by Stifel as ALC Collaboration Announced
View All Articles

Entities mentioned with RXST

View All Entities